Bluemountain Capital Managemen Sells 18,346 Shares of MedEquities Realty Trust (MRT) Stock

MedEquities Realty Trust (NYSE:MRT) Director Bluemountain Capital Managemen sold 18,346 shares of MedEquities Realty Trust stock in a transaction on Wednesday, May 16th. The stock was sold at an average price of $10.32, for a total transaction of $189,330.72. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Bluemountain Capital Managemen also recently made the following trade(s):

  • On Monday, May 14th, Bluemountain Capital Managemen sold 19,316 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.48, for a total transaction of $202,431.68.
  • On Thursday, May 10th, Bluemountain Capital Managemen sold 64,088 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.51, for a total transaction of $673,564.88.
  • On Tuesday, May 8th, Bluemountain Capital Managemen sold 91,623 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.25, for a total transaction of $939,135.75.
  • On Friday, May 4th, Bluemountain Capital Managemen sold 17,674 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.16, for a total transaction of $179,567.84.
  • On Tuesday, May 1st, Bluemountain Capital Managemen sold 24,739 shares of MedEquities Realty Trust stock. The stock was sold at an average price of $10.17, for a total transaction of $251,595.63.

NYSE:MRT traded up $0.07 during trading hours on Thursday, hitting $10.39. The company had a trading volume of 7,183 shares, compared to its average volume of 157,269. The stock has a market cap of $326.84 million, a P/E ratio of 9.05 and a beta of -0.18. MedEquities Realty Trust has a 52 week low of $10.27 and a 52 week high of $10.43.

MedEquities Realty Trust (NYSE:MRT) last released its quarterly earnings results on Thursday, May 10th. The financial services provider reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.30 by ($0.14). The company had revenue of $16.72 million during the quarter, compared to the consensus estimate of $16.41 million. MedEquities Realty Trust had a net margin of 34.63% and a return on equity of 6.17%. analysts predict that MedEquities Realty Trust will post 1.2 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 5th. Investors of record on Tuesday, May 22nd will be issued a $0.21 dividend. This represents a $0.84 annualized dividend and a yield of 8.08%. The ex-dividend date of this dividend is Monday, May 21st. MedEquities Realty Trust’s dividend payout ratio (DPR) is currently 73.68%.

A number of large investors have recently added to or reduced their stakes in the stock. Teachers Insurance & Annuity Association of America boosted its holdings in MedEquities Realty Trust by 26.5% in the first quarter. Teachers Insurance & Annuity Association of America now owns 37,703 shares of the financial services provider’s stock valued at $396,000 after acquiring an additional 7,903 shares in the last quarter. UBS Group AG boosted its holdings in MedEquities Realty Trust by 52.3% in the first quarter. UBS Group AG now owns 23,234 shares of the financial services provider’s stock valued at $244,000 after acquiring an additional 7,978 shares in the last quarter. LSV Asset Management bought a new stake in MedEquities Realty Trust in the fourth quarter valued at $103,000. JPMorgan Chase & Co. bought a new stake in shares of MedEquities Realty Trust during the 3rd quarter valued at $118,000. Finally, Wells Fargo & Company MN boosted its holdings in shares of MedEquities Realty Trust by 43.4% during the 3rd quarter. Wells Fargo & Company MN now owns 35,366 shares of the financial services provider’s stock valued at $416,000 after buying an additional 10,700 shares in the last quarter. Institutional investors and hedge funds own 89.09% of the company’s stock.

Several research analysts recently commented on MRT shares. Citigroup decreased their target price on shares of MedEquities Realty Trust from $12.00 to $10.00 and set a “neutral” rating on the stock in a research note on Thursday, March 1st. B. Riley set a $13.00 target price on shares of MedEquities Realty Trust and gave the stock a “buy” rating in a research note on Monday. ValuEngine downgraded shares of MedEquities Realty Trust from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Cantor Fitzgerald reiterated a “buy” rating and issued a $14.00 price target on shares of MedEquities Realty Trust in a report on Wednesday, February 21st. Finally, JMP Securities set a $13.00 price target on shares of MedEquities Realty Trust and gave the company a “buy” rating in a report on Friday, May 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and four have issued a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $12.43.

MedEquities Realty Trust Company Profile

MedEquities Realty Trust (NYSE: MRT) is a self-managed and self-administered real estate investment trust that invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company's management team has extensive industry experience in acquiring, owning, developing, financing, operating, leasing and monetizing many types of healthcare properties and portfolios.

Insider Buying and Selling by Quarter for MedEquities Realty Trust (NYSE:MRT)

Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply